2000
Marked Increase in L-Selectin–Negative T Cells in Neonatal Pertussis
Hudnall S, Molina C. Marked Increase in L-Selectin–Negative T Cells in Neonatal Pertussis. American Journal Of Clinical Pathology 2000, 114: 35-40. PMID: 10884797, DOI: 10.1309/banx-8jkm-tuqn-4d6p.Peer-Reviewed Original ResearchConceptsPeripheral blood lymphocytesL-selectin expressionT cellsBlood lymphocytesNormal CD4/CD8 ratioCD4/CD8 ratioNaïve T cellsDetailed immunophenotypeNeonatal pertussisCD8 ratioMarked lymphocytosisNK cellsHealthy newbornsHLA-DRLymphoid tissueCord bloodT lymphocytesPertussis toxinB cellsL-selectinLymphocytesFlow cytometryPertussisMarked increaseDramatic finding
1992
Fulminant Epstein‐Barr virus‐associated post‐transplant lymphoproliferative disorders following OKT3 therapy
Canfield C, Hudnall S, Colonna J, Busuttil R, Wilkinson A, Danovitch G, Shaked A, Goldstein L, Rosenthal J. Fulminant Epstein‐Barr virus‐associated post‐transplant lymphoproliferative disorders following OKT3 therapy. Clinical Transplantation 1992, 6: 1-9. DOI: 10.1111/j.1399-0012.1992.tb00580.x.Peer-Reviewed Original ResearchPost-transplant lymphoproliferative disorderLymphoproliferative disordersEpstein-Barr virus-associated post-transplant lymphoproliferative disorderAssociated with Epstein-Barr virusOKT3 monoclonal antibody therapySequelae of immunosuppressionWithdrawal of immunosuppressionMonoclonal antibody therapyPeripheral blood smearEpstein-Barr virusOKT3 therapyAtypical lymphocytesMalignant lymphomaAntibody therapyClinical spectrumProphylactic useImmunosuppressionOKT3Medical CenterBlood smearsAcyclovirTherapyDisordersLymphomaLymphocytes